Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

November 01, 1994; Volume 271,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abe, K

    1. You have access
      Crocin (crocetin di-gentiobiose ester) prevents the inhibitory effect of ethanol on long-term potentiation in the dentate gyrus in vivo.
      M Sugiura, Y Shoyama, H Saito and K Abe
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 703-707;
  2. Adams, M R

    1. You have access
      Effects of estrogen on cardiovascular responses of premenopausal monkeys.
      J K Williams, Y D Kim, M R Adams, M F Chen, A K Myers and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 671-676;
  3. Adams, P

    1. You have access
      (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
      J P Sullivan, M W Decker, J D Brioni, D Donnelly-Roberts, D J Anderson, A W Bannon, C H Kang, P Adams, M Piattoni-Kaplan and M J Buckley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 624-631;
  4. Ali, S

    1. You have access
      Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.
      D D D'Angelo, M G Davis, S Ali and G W Dorn
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1034-1041;
  5. Amici, C

    1. You have access
      Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. II. Regulation of synthesis of inducible p72 heat shock protein.
      P M Lacal, C Amici, E Bonmassar and C D'Onofrio
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1096-1102;
  6. Anderson, D J

    1. You have access
      (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
      J P Sullivan, M W Decker, J D Brioni, D Donnelly-Roberts, D J Anderson, A W Bannon, C H Kang, P Adams, M Piattoni-Kaplan and M J Buckley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 624-631;
    2. You have access
      Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate.
      J J McGuire, D J Anderson and B M Bennett
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 708-714;
  7. Asplund, A

    1. You have access
      Mangafodipir (MnDPDP)-and MnCl2-induced endothelium-dependent relaxation in bovine mesenteric arteries.
      A Asplund, D Grant and J O Karlsson
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 609-614;
  8. Au, J L

    1. You have access
      Effect of interstitial cystitis on drug absorption from urinary bladder.
      X Gao, C A Buffington and J L Au
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 818-823;

B

  1. Bakshi, V P

    1. You have access
      Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.
      V P Bakshi, N R Swerdlow and M A Geyer
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 787-794;
  2. Bannon, A W

    1. You have access
      (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
      J P Sullivan, M W Decker, J D Brioni, D Donnelly-Roberts, D J Anderson, A W Bannon, C H Kang, P Adams, M Piattoni-Kaplan and M J Buckley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 624-631;
  3. Beck, G R

    1. You have access
      Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.
      E H Ohlstein, G R Beck, S A Douglas, P Nambi, M A Lago, J G Gleason, R R Ruffolo, G Feuerstein and J D Elliott
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 762-768;
  4. Bennett, B M

    1. You have access
      Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate.
      J J McGuire, D J Anderson and B M Bennett
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 708-714;
  5. Bienkowski, M J

    1. You have access
      Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
      R B McCall, A G Romero, M J Bienkowski, D W Harris, J C McGuire, M F Piercey, M E Shuck, M W Smith, K A Svensson and P J Schreur
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 875-883;
  6. Bilotta, J M

    1. You have access
      A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.
      M W Lutz, P H Morgan, M K James, P L Feldman, M F Brackeen, A P Lahey, S V James, J M Bilotta and J C Pressley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 795-803;
  7. Binder, J

    1. You have access
      Effect of liposomal methylprednisolone on heart allograft survival and immune function in rats.
      E V Mishina, J Binder, J W Kupiec-Weglinski and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 868-874;
  8. Bonmassar, E

    1. You have access
      Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. I. Cell differentiation determines sensitivity to prostaglandins and virus infection.
      P M Lacal, A Puglianiello, E Bonmassar and C D'Onofrio
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1086-1095;
    2. You have access
      Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. II. Regulation of synthesis of inducible p72 heat shock protein.
      P M Lacal, C Amici, E Bonmassar and C D'Onofrio
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1096-1102;
  9. Bonney, R J

    1. You have access
      Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
      K M Tramposch, F H Chilton, P L Stanley, R C Franson, M B Havens, D O Nettleton, L B Davern, I M Darling and R J Bonney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 852-859;
  10. Brackeen, M F

    1. You have access
      A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.
      M W Lutz, P H Morgan, M K James, P L Feldman, M F Brackeen, A P Lahey, S V James, J M Bilotta and J C Pressley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 795-803;
  11. Branch, C A

    1. You have access
      Causes of differential cardiovascular sensitivity to cocaine. II: Sympathetic, metabolic and cardiac effects.
      C A Branch and M M Knuepfer
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1103-1113;
  12. Brem, S

    1. You have access
      A diaminoantraquinone inhibitor of angiogenesis.
      S Takano, S Gately, J B Jiang and S Brem
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1027-1033;
  13. Breuer, D K

    1. You have access
      Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.
      O Laneuville, D K Breuer, D L Dewitt, T Hla, C D Funk and W L Smith
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 927-934;
  14. Brioni, J D

    1. You have access
      (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
      J P Sullivan, M W Decker, J D Brioni, D Donnelly-Roberts, D J Anderson, A W Bannon, C H Kang, P Adams, M Piattoni-Kaplan and M J Buckley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 624-631;
  15. Brooks, D P

    1. You have access
      Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.
      P Nambi, N Elshourbagy, H L Wu, M Pullen, E H Ohlstein, D P Brooks, M A Lago, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 755-761;
    2. You have access
      Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.
      D P Brooks, P D dePalma, M Gellai, P Nambi, E H Ohlstein, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 769-775;
  16. Buccafusco, J J

    1. You have access
      Effect of chronic central treatment with the acetylcholine analog methylcarbamylcholine on cortical nicotinic receptors: correlation between receptor changes and behavioral function.
      X Yang and J J Buccafusco
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 651-659;
  17. Buckley, M J

    1. You have access
      (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
      J P Sullivan, M W Decker, J D Brioni, D Donnelly-Roberts, D J Anderson, A W Bannon, C H Kang, P Adams, M Piattoni-Kaplan and M J Buckley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 624-631;
  18. Buffington, C A

    1. You have access
      Effect of interstitial cystitis on drug absorption from urinary bladder.
      X Gao, C A Buffington and J L Au
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 818-823;
  19. Burke, T F

    1. You have access
      Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
      T F Burke, J H Woods, J W Lewis and F Medzihradsky
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 715-721;
  20. Butelman, E R

    1. You have access
      Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
      L R Gerak, E R Butelman, J H Woods and C P France
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 993-999;
  21. Bylund, D B

    1. You have access
      Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors.
      M F O'Rourke, L J Iversen, J W Lomasney and D B Bylund
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 735-740;

C

  1. Chan, S

    1. You have access
      Strychnine-binding proteins in intestinal cells: novel brucine binding site with binding affinities for alkaloids.
      H Farrington, F Mendelsohn, S Chan, L Reinlib and S E Guggino
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1074-1079;
  2. Chen, J

    1. You have access
      Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors.
      B J Undem, S N Meeker and J Chen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 811-817;
  3. Chen, M F

    1. You have access
      Effects of estrogen on cardiovascular responses of premenopausal monkeys.
      J K Williams, Y D Kim, M R Adams, M F Chen, A K Myers and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 671-676;
  4. Chiba, K

    1. You have access
      Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.
      E Koyama, D R Sohn, S G Shin, K Chiba, J G Shin, Y H Kim, H Echizen and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 860-867;
  5. Chilton, F H

    1. You have access
      Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
      K M Tramposch, F H Chilton, P L Stanley, R C Franson, M B Havens, D O Nettleton, L B Davern, I M Darling and R J Bonney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 852-859;
  6. Chu, H

    1. You have access
      m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine are partial agonists at cloned 5-HT2A receptors expressed in fibroblasts.
      M S Grotewiel, H Chu and E Sanders-Bush
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1122-1126;
  7. Clement, M E

    1. You have access
      Tolerance development to the vagal-mediated bradycardia produced by 5-HT1A receptor agonists.
      R B McCall, N A Escandon, L T Harris and M E Clement
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 776-781;
  8. Cohen, M L

    1. You have access
      Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysis.
      S W Watts, D A Cox, B G Johnson, D D Schoepp and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 832-844;
  9. Conanan, N D

    1. You have access
      Effect of potassium channel blockers on relaxations to a nitric oxide donor and to nonadrenergic nerve stimulation in guinea pig trachea.
      J L Ellis and N D Conanan
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 782-786;
  10. Cox, D A

    1. You have access
      Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysis.
      S W Watts, D A Cox, B G Johnson, D D Schoepp and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 832-844;

D

  1. D'Angelo, D D

    1. You have access
      Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.
      D D D'Angelo, M G Davis, S Ali and G W Dorn
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1034-1041;
  2. D'Onofrio, C

    1. You have access
      Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. I. Cell differentiation determines sensitivity to prostaglandins and virus infection.
      P M Lacal, A Puglianiello, E Bonmassar and C D'Onofrio
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1086-1095;
    2. You have access
      Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. II. Regulation of synthesis of inducible p72 heat shock protein.
      P M Lacal, C Amici, E Bonmassar and C D'Onofrio
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1096-1102;
  3. Dahlén, S E

    1. You have access
      Interactions between leukotrienes and histamine in the anaphylactic contraction of guinea pig lung parenchyma.
      E W Jonsson and S E Dahlén
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 615-623;
  4. Dains, K

    1. You have access
      Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy.
      B Hitzemann, K Dains, S Kanes and R Hitzemann
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 969-976;
  5. Darling, I M

    1. You have access
      Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
      K M Tramposch, F H Chilton, P L Stanley, R C Franson, M B Havens, D O Nettleton, L B Davern, I M Darling and R J Bonney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 852-859;
  6. Davern, L B

    1. You have access
      Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
      K M Tramposch, F H Chilton, P L Stanley, R C Franson, M B Havens, D O Nettleton, L B Davern, I M Darling and R J Bonney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 852-859;
  7. Davis, M G

    1. You have access
      Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.
      D D D'Angelo, M G Davis, S Ali and G W Dorn
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1034-1041;
  8. Decker, M W

    1. You have access
      (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
      J P Sullivan, M W Decker, J D Brioni, D Donnelly-Roberts, D J Anderson, A W Bannon, C H Kang, P Adams, M Piattoni-Kaplan and M J Buckley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 624-631;
  9. dePalma, P D

    1. You have access
      Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.
      D P Brooks, P D dePalma, M Gellai, P Nambi, E H Ohlstein, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 769-775;
  10. Dewitt, D L

    1. You have access
      Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.
      O Laneuville, D K Breuer, D L Dewitt, T Hla, C D Funk and W L Smith
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 927-934;
  11. Donnelly-Roberts, D

    1. You have access
      (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
      J P Sullivan, M W Decker, J D Brioni, D Donnelly-Roberts, D J Anderson, A W Bannon, C H Kang, P Adams, M Piattoni-Kaplan and M J Buckley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 624-631;
  12. Dorn, G W

    1. You have access
      Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.
      D D D'Angelo, M G Davis, S Ali and G W Dorn
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1034-1041;
  13. Douglas, S A

    1. You have access
      Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.
      E H Ohlstein, G R Beck, S A Douglas, P Nambi, M A Lago, J G Gleason, R R Ruffolo, G Feuerstein and J D Elliott
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 762-768;

E

  1. Echizen, H

    1. You have access
      Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.
      E Koyama, D R Sohn, S G Shin, K Chiba, J G Shin, Y H Kim, H Echizen and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 860-867;
  2. Eglen, R M

    1. You have access
      Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice.
      S S Hedge, T M Moy, M R Perry, M Loeb and R M Eglen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 741-747;
  3. Ehlert, F J

    1. You have access
      Pertussis toxin blocks M2 muscarinic receptor-mediated effects on contraction and cyclic AMP in the guinea pig ileum, but not M3-mediated contractions and phosphoinositide hydrolysis.
      E A Thomas and F J Ehlert
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1042-1050;
  4. Elder, M G

    1. You have access
      Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies.
      G A Knock, M H Sullivan, A McCarthy, M G Elder, J M Polak and J Wharton
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1007-1015;
  5. Elliott, J D

    1. You have access
      Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.
      P Nambi, N Elshourbagy, H L Wu, M Pullen, E H Ohlstein, D P Brooks, M A Lago, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 755-761;
    2. You have access
      Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.
      E H Ohlstein, G R Beck, S A Douglas, P Nambi, M A Lago, J G Gleason, R R Ruffolo, G Feuerstein and J D Elliott
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 762-768;
    3. You have access
      Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.
      D P Brooks, P D dePalma, M Gellai, P Nambi, E H Ohlstein, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 769-775;
  6. Ellis, J L

    1. You have access
      Effect of potassium channel blockers on relaxations to a nitric oxide donor and to nonadrenergic nerve stimulation in guinea pig trachea.
      J L Ellis and N D Conanan
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 782-786;
  7. Elshourbagy, N

    1. You have access
      Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.
      P Nambi, N Elshourbagy, H L Wu, M Pullen, E H Ohlstein, D P Brooks, M A Lago, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 755-761;
  8. Escandon, N A

    1. You have access
      Tolerance development to the vagal-mediated bradycardia produced by 5-HT1A receptor agonists.
      R B McCall, N A Escandon, L T Harris and M E Clement
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 776-781;
  9. Evans, S M

    1. You have access
      Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
      S M Evans, J R Troisi and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 683-694;

F

  1. Farrington, H

    1. You have access
      Strychnine-binding proteins in intestinal cells: novel brucine binding site with binding affinities for alkaloids.
      H Farrington, F Mendelsohn, S Chan, L Reinlib and S E Guggino
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1074-1079;
  2. Feldman, P L

    1. You have access
      A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.
      M W Lutz, P H Morgan, M K James, P L Feldman, M F Brackeen, A P Lahey, S V James, J M Bilotta and J C Pressley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 795-803;
  3. Feuerstein, G

    1. You have access
      Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.
      E H Ohlstein, G R Beck, S A Douglas, P Nambi, M A Lago, J G Gleason, R R Ruffolo, G Feuerstein and J D Elliott
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 762-768;
  4. Fibiger, H C

    1. You have access
      Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity.
      G S Robertson, H Matsumura and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1058-1066;
  5. Fink, G D

    1. You have access
      Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
      V J Gorbea-Oppliger, M G Melaragno, G S Potter, R L Petit and G D Fink
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 804-810;
  6. Fischer, J B

    1. You have access
      In vitro neuroprotection by substituted guanidines with varying affinities for the N-methyl-D-aspartate receptor ionophore and for sigma sites.
      C J Kirk, N L Reddy, J B Fischer, T C Wolcott, A G Knapp and R N McBurney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1080-1085;
  7. Fox-Threlkeld, J A

    1. You have access
      Nitric oxide (NO) inhibits release of acetylcholine from nerves of isolated circular muscle of the canine ileum: relationship to motility and release of nitric oxide.
      L M Hryhorenko, Z Woskowska and J A Fox-Threlkeld
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 918-926;
  8. France, C P

    1. You have access
      Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
      L R Gerak, E R Butelman, J H Woods and C P France
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 993-999;
  9. Franson, R C

    1. You have access
      Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
      K M Tramposch, F H Chilton, P L Stanley, R C Franson, M B Havens, D O Nettleton, L B Davern, I M Darling and R J Bonney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 852-859;
  10. Funk, C D

    1. You have access
      Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.
      O Laneuville, D K Breuer, D L Dewitt, T Hla, C D Funk and W L Smith
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 927-934;

G

  1. Gao, X

    1. You have access
      Effect of interstitial cystitis on drug absorption from urinary bladder.
      X Gao, C A Buffington and J L Au
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 818-823;
  2. Gately, S

    1. You have access
      A diaminoantraquinone inhibitor of angiogenesis.
      S Takano, S Gately, J B Jiang and S Brem
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1027-1033;
  3. Gellai, M

    1. You have access
      Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.
      D P Brooks, P D dePalma, M Gellai, P Nambi, E H Ohlstein, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 769-775;
  4. Gerak, L R

    1. You have access
      Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
      L R Gerak, E R Butelman, J H Woods and C P France
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 993-999;
  5. Geyer, M A

    1. You have access
      Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.
      V P Bakshi, N R Swerdlow and M A Geyer
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 787-794;
  6. Gleason, J G

    1. You have access
      Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.
      P Nambi, N Elshourbagy, H L Wu, M Pullen, E H Ohlstein, D P Brooks, M A Lago, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 755-761;
    2. You have access
      Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.
      E H Ohlstein, G R Beck, S A Douglas, P Nambi, M A Lago, J G Gleason, R R Ruffolo, G Feuerstein and J D Elliott
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 762-768;
    3. You have access
      Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.
      D P Brooks, P D dePalma, M Gellai, P Nambi, E H Ohlstein, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 769-775;
  7. Gögelein, H

    1. You have access
      Inhibition of K+ channels by chlorpromazine in rat ventricular myocytes.
      K Kon, E Krause and H Gögelein
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 632-637;
  8. Gorbea-Oppliger, V J

    1. You have access
      Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
      V J Gorbea-Oppliger, M G Melaragno, G S Potter, R L Petit and G D Fink
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 804-810;
  9. Gorman, A J

    1. You have access
      Role of vascular alpha-1 adrenoceptor subtypes in the pressor response to sympathetic nerve stimulation in the pithed rat.
      H M Vargas, L Zhou and A J Gorman
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 748-754;
  10. Goudreau, J L

    1. You have access
      gamma-Aminobutyric acid receptor-mediated regulation of periventricular-hypophysial dopaminergic neurons: possible role in mediating stress- and 5-hydroxytryptamine-induced decreases in neuronal activity.
      J L Goudreau, E J Wagner, K J Lookingland and K E Moore
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1000-1006;
  11. Grant, D

    1. You have access
      Mangafodipir (MnDPDP)-and MnCl2-induced endothelium-dependent relaxation in bovine mesenteric arteries.
      A Asplund, D Grant and J O Karlsson
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 609-614;
  12. Green-Johnson, J M

    1. You have access
      Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system.
      S Zalcman, J M Green-Johnson, L Murray, W Wan, D M Nance and A H Greenberg
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 977-982;
  13. Greenberg, A H

    1. You have access
      Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system.
      S Zalcman, J M Green-Johnson, L Murray, W Wan, D M Nance and A H Greenberg
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 977-982;
  14. Griffiths, R R

    1. You have access
      Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
      S M Evans, J R Troisi and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 683-694;
  15. Grisham, M B

    1. You have access
      Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis.
      M B Grisham, R D Specian and T E Zimmerman
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1114-1121;
  16. Grotewiel, M S

    1. You have access
      m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine are partial agonists at cloned 5-HT2A receptors expressed in fibroblasts.
      M S Grotewiel, H Chu and E Sanders-Bush
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1122-1126;
  17. Guggino, S E

    1. You have access
      Strychnine-binding proteins in intestinal cells: novel brucine binding site with binding affinities for alkaloids.
      H Farrington, F Mendelsohn, S Chan, L Reinlib and S E Guggino
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1074-1079;

H

  1. Hammond, J R

    1. You have access
      Functional reconstitution of pharmacologically distinct subtypes of nucleoside transporters in liposomal membranes.
      J R Hammond
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 906-917;
  2. Harbison, R D

    1. You have access
      Methamphetamine potentiation of carbon tetrachloride hepatotoxicity in mice.
      S M Roberts, R D Harbison and R C James
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1051-1057;
  3. Harris, D W

    1. You have access
      Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
      R B McCall, A G Romero, M J Bienkowski, D W Harris, J C McGuire, M F Piercey, M E Shuck, M W Smith, K A Svensson and P J Schreur
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 875-883;
  4. Harris, L T

    1. You have access
      Tolerance development to the vagal-mediated bradycardia produced by 5-HT1A receptor agonists.
      R B McCall, N A Escandon, L T Harris and M E Clement
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 776-781;
  5. Harris, R A

    1. You have access
      Alcohols and anesthetics enhance the function of 5-hydroxytryptamine3 receptors expressed in Xenopus laevis oocytes.
      T K Machu and R A Harris
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 898-905;
  6. Havens, M B

    1. You have access
      Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
      K M Tramposch, F H Chilton, P L Stanley, R C Franson, M B Havens, D O Nettleton, L B Davern, I M Darling and R J Bonney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 852-859;
  7. Hedge, S S

    1. You have access
      Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice.
      S S Hedge, T M Moy, M R Perry, M Loeb and R M Eglen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 741-747;
  8. Hitzemann, B

    1. You have access
      Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy.
      B Hitzemann, K Dains, S Kanes and R Hitzemann
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 969-976;
  9. Hitzemann, R

    1. You have access
      Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy.
      B Hitzemann, K Dains, S Kanes and R Hitzemann
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 969-976;
  10. Hla, T

    1. You have access
      Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.
      O Laneuville, D K Breuer, D L Dewitt, T Hla, C D Funk and W L Smith
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 927-934;
  11. House, J D

    1. You have access
      In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
      E A Walker, M M Makhay, J D House and A M Young
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 959-968;
  12. Hryhorenko, L M

    1. You have access
      Nitric oxide (NO) inhibits release of acetylcholine from nerves of isolated circular muscle of the canine ileum: relationship to motility and release of nitric oxide.
      L M Hryhorenko, Z Woskowska and J A Fox-Threlkeld
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 918-926;

I

  1. Irwin, R P

    1. You have access
      Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies.
      R P Irwin, S Z Lin, M A Rogawski, R H Purdy and S M Paul
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 677-682;
  2. Ishizaki, T

    1. You have access
      Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.
      E Koyama, D R Sohn, S G Shin, K Chiba, J G Shin, Y H Kim, H Echizen and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 860-867;
  3. Itoh, Y

    1. You have access
      Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: regional differences and its sites of action.
      Y Itoh, T Ogasawara, T Mushiroi, A yamazaki, Y Ukai and K Kimura
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 884-890;
  4. Iversen, L J

    1. You have access
      Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors.
      M F O'Rourke, L J Iversen, J W Lomasney and D B Bylund
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 735-740;
  5. Iwamoto, E T

    1. You have access
      Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats.
      E T Iwamoto and L Marion
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 601-608;

J

  1. James, M K

    1. You have access
      A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.
      M W Lutz, P H Morgan, M K James, P L Feldman, M F Brackeen, A P Lahey, S V James, J M Bilotta and J C Pressley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 795-803;
  2. James, R C

    1. You have access
      Methamphetamine potentiation of carbon tetrachloride hepatotoxicity in mice.
      S M Roberts, R D Harbison and R C James
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1051-1057;
  3. James, S V

    1. You have access
      A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.
      M W Lutz, P H Morgan, M K James, P L Feldman, M F Brackeen, A P Lahey, S V James, J M Bilotta and J C Pressley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 795-803;
  4. James-Kracke, M R

    1. You have access
      Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.
      M R James-Kracke, R B Sexe and S D Shukla
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 824-831;
  5. Jiang, J B

    1. You have access
      A diaminoantraquinone inhibitor of angiogenesis.
      S Takano, S Gately, J B Jiang and S Brem
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1027-1033;
  6. Johnson, B G

    1. You have access
      Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysis.
      S W Watts, D A Cox, B G Johnson, D D Schoepp and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 832-844;
  7. Jonsson, E W

    1. You have access
      Interactions between leukotrienes and histamine in the anaphylactic contraction of guinea pig lung parenchyma.
      E W Jonsson and S E Dahlén
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 615-623;
  8. Jusko, W J

    1. You have access
      Effect of liposomal methylprednisolone on heart allograft survival and immune function in rats.
      E V Mishina, J Binder, J W Kupiec-Weglinski and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 868-874;

K

  1. Kanes, S

    1. You have access
      Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy.
      B Hitzemann, K Dains, S Kanes and R Hitzemann
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 969-976;
  2. Kang, C H

    1. You have access
      (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
      J P Sullivan, M W Decker, J D Brioni, D Donnelly-Roberts, D J Anderson, A W Bannon, C H Kang, P Adams, M Piattoni-Kaplan and M J Buckley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 624-631;
  3. Karlsson, J O

    1. You have access
      Mangafodipir (MnDPDP)-and MnCl2-induced endothelium-dependent relaxation in bovine mesenteric arteries.
      A Asplund, D Grant and J O Karlsson
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 609-614;
  4. Karpinski, E

    1. You have access
      The L-type calcium channel current is increased by alpha-1 adrenoceptor activation in neonatal rat ventricular cells.
      Q Y Liu, E Karpinski and P K Pang
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 935-943;
    2. You have access
      L-channel modulation by alpha-1 adrenoceptor activation in neonatal rat ventricular cells: intracellular mechanisms.
      Q Y Liu, E Karpinski and P K Pang
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 944-951;
  5. Kim, Y D

    1. You have access
      Effects of estrogen on cardiovascular responses of premenopausal monkeys.
      J K Williams, Y D Kim, M R Adams, M F Chen, A K Myers and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 671-676;
  6. Kim, Y H

    1. You have access
      Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.
      E Koyama, D R Sohn, S G Shin, K Chiba, J G Shin, Y H Kim, H Echizen and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 860-867;
  7. Kimura, K

    1. You have access
      Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: regional differences and its sites of action.
      Y Itoh, T Ogasawara, T Mushiroi, A yamazaki, Y Ukai and K Kimura
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 884-890;
  8. Kirk, C J

    1. You have access
      In vitro neuroprotection by substituted guanidines with varying affinities for the N-methyl-D-aspartate receptor ionophore and for sigma sites.
      C J Kirk, N L Reddy, J B Fischer, T C Wolcott, A G Knapp and R N McBurney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1080-1085;
  9. Knapp, A G

    1. You have access
      In vitro neuroprotection by substituted guanidines with varying affinities for the N-methyl-D-aspartate receptor ionophore and for sigma sites.
      C J Kirk, N L Reddy, J B Fischer, T C Wolcott, A G Knapp and R N McBurney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1080-1085;
  10. Knock, G A

    1. You have access
      Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies.
      G A Knock, M H Sullivan, A McCarthy, M G Elder, J M Polak and J Wharton
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1007-1015;
  11. Knuepfer, M M

    1. You have access
      Causes of differential cardiovascular sensitivity to cocaine. II: Sympathetic, metabolic and cardiac effects.
      C A Branch and M M Knuepfer
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1103-1113;
  12. Kodama, H

    1. You have access
      The differential roles of sympathetic nerve activity in the pathogenesis of antral and corpus lesions induced by indomethacin in rats.
      K Kuratani, H Kodama and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 695-702;
  13. Kon, K

    1. You have access
      Inhibition of K+ channels by chlorpromazine in rat ventricular myocytes.
      K Kon, E Krause and H Gögelein
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 632-637;
  14. Koyama, E

    1. You have access
      Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.
      E Koyama, D R Sohn, S G Shin, K Chiba, J G Shin, Y H Kim, H Echizen and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 860-867;
  15. Krause, E

    1. You have access
      Inhibition of K+ channels by chlorpromazine in rat ventricular myocytes.
      K Kon, E Krause and H Gögelein
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 632-637;
  16. Krause, J E

    1. You have access
      Regulation of the responses to gonadotropin-releasing hormone, muscarine and substance P in sympathetic neurons by changes in cellular constituents and intracellular application of peptide fragments of the substance P receptor.
      M A Simmons, C R Schneider and J E Krause
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 581-589;
  17. Kupiec-Weglinski, J W

    1. You have access
      Effect of liposomal methylprednisolone on heart allograft survival and immune function in rats.
      E V Mishina, J Binder, J W Kupiec-Weglinski and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 868-874;
  18. Kuratani, K

    1. You have access
      The differential roles of sympathetic nerve activity in the pathogenesis of antral and corpus lesions induced by indomethacin in rats.
      K Kuratani, H Kodama and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 695-702;

L

  1. Lacal, P M

    1. You have access
      Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. I. Cell differentiation determines sensitivity to prostaglandins and virus infection.
      P M Lacal, A Puglianiello, E Bonmassar and C D'Onofrio
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1086-1095;
    2. You have access
      Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. II. Regulation of synthesis of inducible p72 heat shock protein.
      P M Lacal, C Amici, E Bonmassar and C D'Onofrio
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1096-1102;
  2. Lago, M A

    1. You have access
      Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.
      P Nambi, N Elshourbagy, H L Wu, M Pullen, E H Ohlstein, D P Brooks, M A Lago, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 755-761;
    2. You have access
      Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.
      E H Ohlstein, G R Beck, S A Douglas, P Nambi, M A Lago, J G Gleason, R R Ruffolo, G Feuerstein and J D Elliott
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 762-768;
  3. Lahey, A P

    1. You have access
      A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.
      M W Lutz, P H Morgan, M K James, P L Feldman, M F Brackeen, A P Lahey, S V James, J M Bilotta and J C Pressley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 795-803;
  4. Laneuville, O

    1. You have access
      Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.
      O Laneuville, D K Breuer, D L Dewitt, T Hla, C D Funk and W L Smith
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 927-934;
  5. Lewis, J W

    1. You have access
      Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
      T F Burke, J H Woods, J W Lewis and F Medzihradsky
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 715-721;
  6. Lin, S Z

    1. You have access
      Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies.
      R P Irwin, S Z Lin, M A Rogawski, R H Purdy and S M Paul
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 677-682;
  7. Liu, Q Y

    1. You have access
      The L-type calcium channel current is increased by alpha-1 adrenoceptor activation in neonatal rat ventricular cells.
      Q Y Liu, E Karpinski and P K Pang
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 935-943;
    2. You have access
      L-channel modulation by alpha-1 adrenoceptor activation in neonatal rat ventricular cells: intracellular mechanisms.
      Q Y Liu, E Karpinski and P K Pang
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 944-951;
  8. Lodge, N J

    1. You have access
      Direct vasoconstrictor effects of sandimmune (cyclosporine A) are mediated by its vehicle cremophor EL: inhibition by the thromboxane A2/prostaglandin endoperoxide receptor antagonist ifetroban.
      N J Lodge
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 730-734;
  9. Loeb, M

    1. You have access
      Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice.
      S S Hedge, T M Moy, M R Perry, M Loeb and R M Eglen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 741-747;
  10. Logue, A R

    1. You have access
      Studies on the role of K+, Cl- and Na+ ion permeabilities in the acetylcholine release enhancing effects of linopirdine (DuP 996) in rat cortical slices.
      C M Maciag, A R Logue, W J Tinker, J A Saydoff, S W Tam and R Zaczek
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 891-897;
  11. Lomasney, J W

    1. You have access
      Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors.
      M F O'Rourke, L J Iversen, J W Lomasney and D B Bylund
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 735-740;
  12. Lookingland, K J

    1. You have access
      gamma-Aminobutyric acid receptor-mediated regulation of periventricular-hypophysial dopaminergic neurons: possible role in mediating stress- and 5-hydroxytryptamine-induced decreases in neuronal activity.
      J L Goudreau, E J Wagner, K J Lookingland and K E Moore
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1000-1006;
  13. Lutz, M W

    1. You have access
      A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.
      M W Lutz, P H Morgan, M K James, P L Feldman, M F Brackeen, A P Lahey, S V James, J M Bilotta and J C Pressley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 795-803;

M

  1. Machu, T K

    1. You have access
      Alcohols and anesthetics enhance the function of 5-hydroxytryptamine3 receptors expressed in Xenopus laevis oocytes.
      T K Machu and R A Harris
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 898-905;
  2. Maciag, C M

    1. You have access
      Studies on the role of K+, Cl- and Na+ ion permeabilities in the acetylcholine release enhancing effects of linopirdine (DuP 996) in rat cortical slices.
      C M Maciag, A R Logue, W J Tinker, J A Saydoff, S W Tam and R Zaczek
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 891-897;
  3. Makhay, M M

    1. You have access
      In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
      E A Walker, M M Makhay, J D House and A M Young
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 959-968;
  4. Malik, K U

    1. You have access
      Attenuation by alpha,beta-methylenadenosine-5'-triphosphate of periarterial nerve stimulation-induced renal vasoconstriction is not due to desensitization of purinergic receptors.
      E Sehic, Y Ruan and K U Malik
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 983-992;
  5. Marion, L

    1. You have access
      Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats.
      E T Iwamoto and L Marion
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 601-608;
  6. Matsumura, H

    1. You have access
      Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity.
      G S Robertson, H Matsumura and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1058-1066;
  7. McBurney, R N

    1. You have access
      In vitro neuroprotection by substituted guanidines with varying affinities for the N-methyl-D-aspartate receptor ionophore and for sigma sites.
      C J Kirk, N L Reddy, J B Fischer, T C Wolcott, A G Knapp and R N McBurney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1080-1085;
  8. McCall, R B

    1. You have access
      Tolerance development to the vagal-mediated bradycardia produced by 5-HT1A receptor agonists.
      R B McCall, N A Escandon, L T Harris and M E Clement
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 776-781;
    2. You have access
      Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
      R B McCall, A G Romero, M J Bienkowski, D W Harris, J C McGuire, M F Piercey, M E Shuck, M W Smith, K A Svensson and P J Schreur
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 875-883;
  9. McCarthy, A

    1. You have access
      Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies.
      G A Knock, M H Sullivan, A McCarthy, M G Elder, J M Polak and J Wharton
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1007-1015;
  10. McGuire, J C

    1. You have access
      Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
      R B McCall, A G Romero, M J Bienkowski, D W Harris, J C McGuire, M F Piercey, M E Shuck, M W Smith, K A Svensson and P J Schreur
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 875-883;
  11. McGuire, J J

    1. You have access
      Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate.
      J J McGuire, D J Anderson and B M Bennett
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 708-714;
  12. Medzihradsky, F

    1. You have access
      Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
      T F Burke, J H Woods, J W Lewis and F Medzihradsky
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 715-721;
  13. Meeker, S N

    1. You have access
      Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors.
      B J Undem, S N Meeker and J Chen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 811-817;
  14. Melaragno, M G

    1. You have access
      Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
      V J Gorbea-Oppliger, M G Melaragno, G S Potter, R L Petit and G D Fink
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 804-810;
  15. Mendelsohn, F

    1. You have access
      Strychnine-binding proteins in intestinal cells: novel brucine binding site with binding affinities for alkaloids.
      H Farrington, F Mendelsohn, S Chan, L Reinlib and S E Guggino
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1074-1079;
  16. Millington, W R

    1. You have access
      Beta-endorphin-induced cardiorespiratory depression is inhibited by glycyl-L-glutamine, a dipeptide derived from beta-endorphin processing.
      C B Unal, M D Owen and W R Millington
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 952-958;
  17. Mishina, E V

    1. You have access
      Effect of liposomal methylprednisolone on heart allograft survival and immune function in rats.
      E V Mishina, J Binder, J W Kupiec-Weglinski and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 868-874;
  18. Mittleman, G

    1. You have access
      Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
      G Mittleman, A L Rosner and C L Schaub
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 638-650;
  19. Moore, K E

    1. You have access
      gamma-Aminobutyric acid receptor-mediated regulation of periventricular-hypophysial dopaminergic neurons: possible role in mediating stress- and 5-hydroxytryptamine-induced decreases in neuronal activity.
      J L Goudreau, E J Wagner, K J Lookingland and K E Moore
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1000-1006;
  20. Morgan, P H

    1. You have access
      A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.
      M W Lutz, P H Morgan, M K James, P L Feldman, M F Brackeen, A P Lahey, S V James, J M Bilotta and J C Pressley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 795-803;
  21. Moy, T M

    1. You have access
      Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice.
      S S Hedge, T M Moy, M R Perry, M Loeb and R M Eglen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 741-747;
  22. Murray, L

    1. You have access
      Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system.
      S Zalcman, J M Green-Johnson, L Murray, W Wan, D M Nance and A H Greenberg
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 977-982;
  23. Mushiroi, T

    1. You have access
      Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: regional differences and its sites of action.
      Y Itoh, T Ogasawara, T Mushiroi, A yamazaki, Y Ukai and K Kimura
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 884-890;
  24. Myers, A K

    1. You have access
      Effects of estrogen on cardiovascular responses of premenopausal monkeys.
      J K Williams, Y D Kim, M R Adams, M F Chen, A K Myers and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 671-676;

N

  1. Nambi, P

    1. You have access
      Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.
      P Nambi, N Elshourbagy, H L Wu, M Pullen, E H Ohlstein, D P Brooks, M A Lago, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 755-761;
    2. You have access
      Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.
      E H Ohlstein, G R Beck, S A Douglas, P Nambi, M A Lago, J G Gleason, R R Ruffolo, G Feuerstein and J D Elliott
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 762-768;
    3. You have access
      Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.
      D P Brooks, P D dePalma, M Gellai, P Nambi, E H Ohlstein, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 769-775;
  2. Nance, D M

    1. You have access
      Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system.
      S Zalcman, J M Green-Johnson, L Murray, W Wan, D M Nance and A H Greenberg
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 977-982;
  3. Nettleton, D O

    1. You have access
      Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
      K M Tramposch, F H Chilton, P L Stanley, R C Franson, M B Havens, D O Nettleton, L B Davern, I M Darling and R J Bonney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 852-859;

O

  1. O'Rourke, M F

    1. You have access
      Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors.
      M F O'Rourke, L J Iversen, J W Lomasney and D B Bylund
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 735-740;
  2. Ogasawara, T

    1. You have access
      Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: regional differences and its sites of action.
      Y Itoh, T Ogasawara, T Mushiroi, A yamazaki, Y Ukai and K Kimura
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 884-890;
  3. Ohlstein, E H

    1. You have access
      Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.
      P Nambi, N Elshourbagy, H L Wu, M Pullen, E H Ohlstein, D P Brooks, M A Lago, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 755-761;
    2. You have access
      Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.
      E H Ohlstein, G R Beck, S A Douglas, P Nambi, M A Lago, J G Gleason, R R Ruffolo, G Feuerstein and J D Elliott
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 762-768;
    3. You have access
      Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.
      D P Brooks, P D dePalma, M Gellai, P Nambi, E H Ohlstein, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 769-775;
  4. Orihata, M

    1. You have access
      Inhibition of nitric oxide synthase delays gastric emptying of solid meals.
      M Orihata and S K Sarna
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 660-670;
  5. Owen, M D

    1. You have access
      Beta-endorphin-induced cardiorespiratory depression is inhibited by glycyl-L-glutamine, a dipeptide derived from beta-endorphin processing.
      C B Unal, M D Owen and W R Millington
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 952-958;

P

  1. Pampori, N A

    1. You have access
      Over-expression of CYP2C11, the major male-specific form of hepatic cytochrome P450, in the presence of nominal pulses of circulating growth hormone in adult male rats neonatally exposed to low levels of monosodium glutamate.
      N A Pampori and B H Shapiro
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1067-1073;
  2. Pang, P K

    1. You have access
      The L-type calcium channel current is increased by alpha-1 adrenoceptor activation in neonatal rat ventricular cells.
      Q Y Liu, E Karpinski and P K Pang
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 935-943;
    2. You have access
      L-channel modulation by alpha-1 adrenoceptor activation in neonatal rat ventricular cells: intracellular mechanisms.
      Q Y Liu, E Karpinski and P K Pang
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 944-951;
  3. Paul, S M

    1. You have access
      Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies.
      R P Irwin, S Z Lin, M A Rogawski, R H Purdy and S M Paul
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 677-682;
  4. Perry, M R

    1. You have access
      Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice.
      S S Hedge, T M Moy, M R Perry, M Loeb and R M Eglen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 741-747;
  5. Petit, R L

    1. You have access
      Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
      V J Gorbea-Oppliger, M G Melaragno, G S Potter, R L Petit and G D Fink
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 804-810;
  6. Piattoni-Kaplan, M

    1. You have access
      (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
      J P Sullivan, M W Decker, J D Brioni, D Donnelly-Roberts, D J Anderson, A W Bannon, C H Kang, P Adams, M Piattoni-Kaplan and M J Buckley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 624-631;
  7. Piercey, M F

    1. You have access
      Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
      R B McCall, A G Romero, M J Bienkowski, D W Harris, J C McGuire, M F Piercey, M E Shuck, M W Smith, K A Svensson and P J Schreur
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 875-883;
  8. Polak, J M

    1. You have access
      Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies.
      G A Knock, M H Sullivan, A McCarthy, M G Elder, J M Polak and J Wharton
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1007-1015;
  9. Potter, G S

    1. You have access
      Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
      V J Gorbea-Oppliger, M G Melaragno, G S Potter, R L Petit and G D Fink
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 804-810;
  10. Pressley, J C

    1. You have access
      A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.
      M W Lutz, P H Morgan, M K James, P L Feldman, M F Brackeen, A P Lahey, S V James, J M Bilotta and J C Pressley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 795-803;
  11. Prior, T

    1. You have access
      Functional subtyping of histamine receptors on the canine proximal colonic mucosa.
      P K Rangachari and T Prior
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1016-1026;
  12. Pruett, S B

    1. You have access
      Ethanol decreases the number and activity of splenic natural killer cells in a mouse model for binge drinking.
      W J Wu, R M Wolcott and S B Pruett
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 722-729;
  13. Puglianiello, A

    1. You have access
      Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. I. Cell differentiation determines sensitivity to prostaglandins and virus infection.
      P M Lacal, A Puglianiello, E Bonmassar and C D'Onofrio
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1086-1095;
  14. Pullen, M

    1. You have access
      Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.
      P Nambi, N Elshourbagy, H L Wu, M Pullen, E H Ohlstein, D P Brooks, M A Lago, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 755-761;
  15. Purdy, R H

    1. You have access
      Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies.
      R P Irwin, S Z Lin, M A Rogawski, R H Purdy and S M Paul
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 677-682;

R

  1. Ramwell, P W

    1. You have access
      Effects of estrogen on cardiovascular responses of premenopausal monkeys.
      J K Williams, Y D Kim, M R Adams, M F Chen, A K Myers and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 671-676;
  2. Rangachari, P K

    1. You have access
      Functional subtyping of histamine receptors on the canine proximal colonic mucosa.
      P K Rangachari and T Prior
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1016-1026;
  3. Reddy, N L

    1. You have access
      In vitro neuroprotection by substituted guanidines with varying affinities for the N-methyl-D-aspartate receptor ionophore and for sigma sites.
      C J Kirk, N L Reddy, J B Fischer, T C Wolcott, A G Knapp and R N McBurney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1080-1085;
  4. Reinlib, L

    1. You have access
      Strychnine-binding proteins in intestinal cells: novel brucine binding site with binding affinities for alkaloids.
      H Farrington, F Mendelsohn, S Chan, L Reinlib and S E Guggino
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1074-1079;
  5. Roberts, S M

    1. You have access
      Methamphetamine potentiation of carbon tetrachloride hepatotoxicity in mice.
      S M Roberts, R D Harbison and R C James
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1051-1057;
  6. Robertson, G S

    1. You have access
      Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity.
      G S Robertson, H Matsumura and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1058-1066;
  7. Rogawski, M A

    1. You have access
      Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies.
      R P Irwin, S Z Lin, M A Rogawski, R H Purdy and S M Paul
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 677-682;
  8. Romero, A G

    1. You have access
      Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
      R B McCall, A G Romero, M J Bienkowski, D W Harris, J C McGuire, M F Piercey, M E Shuck, M W Smith, K A Svensson and P J Schreur
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 875-883;
  9. Rosner, A L

    1. You have access
      Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
      G Mittleman, A L Rosner and C L Schaub
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 638-650;
  10. Ruan, Y

    1. You have access
      Attenuation by alpha,beta-methylenadenosine-5'-triphosphate of periarterial nerve stimulation-induced renal vasoconstriction is not due to desensitization of purinergic receptors.
      E Sehic, Y Ruan and K U Malik
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 983-992;
  11. Ruffolo, R R

    1. You have access
      Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.
      P Nambi, N Elshourbagy, H L Wu, M Pullen, E H Ohlstein, D P Brooks, M A Lago, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 755-761;
    2. You have access
      Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.
      E H Ohlstein, G R Beck, S A Douglas, P Nambi, M A Lago, J G Gleason, R R Ruffolo, G Feuerstein and J D Elliott
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 762-768;
    3. You have access
      Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.
      D P Brooks, P D dePalma, M Gellai, P Nambi, E H Ohlstein, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 769-775;

S

  1. Saito, H

    1. You have access
      Crocin (crocetin di-gentiobiose ester) prevents the inhibitory effect of ethanol on long-term potentiation in the dentate gyrus in vivo.
      M Sugiura, Y Shoyama, H Saito and K Abe
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 703-707;
  2. Sanders-Bush, E

    1. You have access
      m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine are partial agonists at cloned 5-HT2A receptors expressed in fibroblasts.
      M S Grotewiel, H Chu and E Sanders-Bush
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1122-1126;
  3. Sarna, S K

    1. You have access
      Inhibition of nitric oxide synthase delays gastric emptying of solid meals.
      M Orihata and S K Sarna
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 660-670;
  4. Saydoff, J A

    1. You have access
      Studies on the role of K+, Cl- and Na+ ion permeabilities in the acetylcholine release enhancing effects of linopirdine (DuP 996) in rat cortical slices.
      C M Maciag, A R Logue, W J Tinker, J A Saydoff, S W Tam and R Zaczek
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 891-897;
  5. Schaub, C L

    1. You have access
      Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
      G Mittleman, A L Rosner and C L Schaub
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 638-650;
  6. Schneider, C R

    1. You have access
      Regulation of the responses to gonadotropin-releasing hormone, muscarine and substance P in sympathetic neurons by changes in cellular constituents and intracellular application of peptide fragments of the substance P receptor.
      M A Simmons, C R Schneider and J E Krause
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 581-589;
  7. Schoepp, D D

    1. You have access
      Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysis.
      S W Watts, D A Cox, B G Johnson, D D Schoepp and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 832-844;
  8. Schreur, P J

    1. You have access
      Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
      R B McCall, A G Romero, M J Bienkowski, D W Harris, J C McGuire, M F Piercey, M E Shuck, M W Smith, K A Svensson and P J Schreur
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 875-883;
  9. Sehic, E

    1. You have access
      Attenuation by alpha,beta-methylenadenosine-5'-triphosphate of periarterial nerve stimulation-induced renal vasoconstriction is not due to desensitization of purinergic receptors.
      E Sehic, Y Ruan and K U Malik
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 983-992;
  10. Sexe, R B

    1. You have access
      Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.
      M R James-Kracke, R B Sexe and S D Shukla
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 824-831;
  11. Shapiro, B H

    1. You have access
      Over-expression of CYP2C11, the major male-specific form of hepatic cytochrome P450, in the presence of nominal pulses of circulating growth hormone in adult male rats neonatally exposed to low levels of monosodium glutamate.
      N A Pampori and B H Shapiro
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1067-1073;
  12. Shin, J G

    1. You have access
      Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.
      E Koyama, D R Sohn, S G Shin, K Chiba, J G Shin, Y H Kim, H Echizen and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 860-867;
  13. Shin, S G

    1. You have access
      Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.
      E Koyama, D R Sohn, S G Shin, K Chiba, J G Shin, Y H Kim, H Echizen and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 860-867;
  14. Shinnick-Gallagher, P

    1. You have access
      Interleukin-1 beta inhibits synaptic transmission and induces membrane hyperpolarization in amygdala neurons.
      B Yu and P Shinnick-Gallagher
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 590-600;
  15. Shoyama, Y

    1. You have access
      Crocin (crocetin di-gentiobiose ester) prevents the inhibitory effect of ethanol on long-term potentiation in the dentate gyrus in vivo.
      M Sugiura, Y Shoyama, H Saito and K Abe
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 703-707;
  16. Shuck, M E

    1. You have access
      Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
      R B McCall, A G Romero, M J Bienkowski, D W Harris, J C McGuire, M F Piercey, M E Shuck, M W Smith, K A Svensson and P J Schreur
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 875-883;
  17. Shukla, S D

    1. You have access
      Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.
      M R James-Kracke, R B Sexe and S D Shukla
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 824-831;
  18. Simmons, M A

    1. You have access
      Regulation of the responses to gonadotropin-releasing hormone, muscarine and substance P in sympathetic neurons by changes in cellular constituents and intracellular application of peptide fragments of the substance P receptor.
      M A Simmons, C R Schneider and J E Krause
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 581-589;
  19. Smith, M W

    1. You have access
      Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
      R B McCall, A G Romero, M J Bienkowski, D W Harris, J C McGuire, M F Piercey, M E Shuck, M W Smith, K A Svensson and P J Schreur
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 875-883;
  20. Smith, W L

    1. You have access
      Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.
      O Laneuville, D K Breuer, D L Dewitt, T Hla, C D Funk and W L Smith
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 927-934;
  21. Sohn, D R

    1. You have access
      Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.
      E Koyama, D R Sohn, S G Shin, K Chiba, J G Shin, Y H Kim, H Echizen and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 860-867;
  22. Specian, R D

    1. You have access
      Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis.
      M B Grisham, R D Specian and T E Zimmerman
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1114-1121;
  23. Stanley, P L

    1. You have access
      Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
      K M Tramposch, F H Chilton, P L Stanley, R C Franson, M B Havens, D O Nettleton, L B Davern, I M Darling and R J Bonney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 852-859;
  24. Sugiura, M

    1. You have access
      Crocin (crocetin di-gentiobiose ester) prevents the inhibitory effect of ethanol on long-term potentiation in the dentate gyrus in vivo.
      M Sugiura, Y Shoyama, H Saito and K Abe
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 703-707;
  25. Sullivan, J P

    1. You have access
      (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
      J P Sullivan, M W Decker, J D Brioni, D Donnelly-Roberts, D J Anderson, A W Bannon, C H Kang, P Adams, M Piattoni-Kaplan and M J Buckley
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 624-631;
  26. Sullivan, M H

    1. You have access
      Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies.
      G A Knock, M H Sullivan, A McCarthy, M G Elder, J M Polak and J Wharton
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1007-1015;
  27. Svensson, K A

    1. You have access
      Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
      R B McCall, A G Romero, M J Bienkowski, D W Harris, J C McGuire, M F Piercey, M E Shuck, M W Smith, K A Svensson and P J Schreur
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 875-883;
  28. Swerdlow, N R

    1. You have access
      Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.
      V P Bakshi, N R Swerdlow and M A Geyer
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 787-794;

T

  1. Takano, S

    1. You have access
      A diaminoantraquinone inhibitor of angiogenesis.
      S Takano, S Gately, J B Jiang and S Brem
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1027-1033;
  2. Tam, S W

    1. You have access
      Studies on the role of K+, Cl- and Na+ ion permeabilities in the acetylcholine release enhancing effects of linopirdine (DuP 996) in rat cortical slices.
      C M Maciag, A R Logue, W J Tinker, J A Saydoff, S W Tam and R Zaczek
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 891-897;
  3. Thomas, E A

    1. You have access
      Pertussis toxin blocks M2 muscarinic receptor-mediated effects on contraction and cyclic AMP in the guinea pig ileum, but not M3-mediated contractions and phosphoinositide hydrolysis.
      E A Thomas and F J Ehlert
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1042-1050;
  4. Tinker, W J

    1. You have access
      Studies on the role of K+, Cl- and Na+ ion permeabilities in the acetylcholine release enhancing effects of linopirdine (DuP 996) in rat cortical slices.
      C M Maciag, A R Logue, W J Tinker, J A Saydoff, S W Tam and R Zaczek
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 891-897;
  5. Tramposch, K M

    1. You have access
      Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
      K M Tramposch, F H Chilton, P L Stanley, R C Franson, M B Havens, D O Nettleton, L B Davern, I M Darling and R J Bonney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 852-859;
  6. Troisi, J R

    1. You have access
      Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
      S M Evans, J R Troisi and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 683-694;

U

  1. Ukai, Y

    1. You have access
      Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: regional differences and its sites of action.
      Y Itoh, T Ogasawara, T Mushiroi, A yamazaki, Y Ukai and K Kimura
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 884-890;
  2. Unal, C B

    1. You have access
      Beta-endorphin-induced cardiorespiratory depression is inhibited by glycyl-L-glutamine, a dipeptide derived from beta-endorphin processing.
      C B Unal, M D Owen and W R Millington
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 952-958;
  3. Undem, B J

    1. You have access
      Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors.
      B J Undem, S N Meeker and J Chen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 811-817;

V

  1. Vargas, H M

    1. You have access
      Role of vascular alpha-1 adrenoceptor subtypes in the pressor response to sympathetic nerve stimulation in the pithed rat.
      H M Vargas, L Zhou and A J Gorman
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 748-754;

W

  1. Wagner, E J

    1. You have access
      gamma-Aminobutyric acid receptor-mediated regulation of periventricular-hypophysial dopaminergic neurons: possible role in mediating stress- and 5-hydroxytryptamine-induced decreases in neuronal activity.
      J L Goudreau, E J Wagner, K J Lookingland and K E Moore
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1000-1006;
  2. Walker, E A

    1. You have access
      In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
      E A Walker, M M Makhay, J D House and A M Young
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 959-968;
  3. Wan, W

    1. You have access
      Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system.
      S Zalcman, J M Green-Johnson, L Murray, W Wan, D M Nance and A H Greenberg
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 977-982;
  4. Wanstall, J C

    1. You have access
      In vitro hypoxia attenuates vasorelaxation by potassium channel opening drugs and nitroprusside in isolated pulmonary arteries from rats.
      J C Wanstall
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 845-851;
  5. Watts, S W

    1. You have access
      Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysis.
      S W Watts, D A Cox, B G Johnson, D D Schoepp and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 832-844;
  6. Wharton, J

    1. You have access
      Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies.
      G A Knock, M H Sullivan, A McCarthy, M G Elder, J M Polak and J Wharton
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1007-1015;
  7. Williams, J K

    1. You have access
      Effects of estrogen on cardiovascular responses of premenopausal monkeys.
      J K Williams, Y D Kim, M R Adams, M F Chen, A K Myers and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 671-676;
  8. Wolcott, R M

    1. You have access
      Ethanol decreases the number and activity of splenic natural killer cells in a mouse model for binge drinking.
      W J Wu, R M Wolcott and S B Pruett
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 722-729;
  9. Wolcott, T C

    1. You have access
      In vitro neuroprotection by substituted guanidines with varying affinities for the N-methyl-D-aspartate receptor ionophore and for sigma sites.
      C J Kirk, N L Reddy, J B Fischer, T C Wolcott, A G Knapp and R N McBurney
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1080-1085;
  10. Woods, J H

    1. You have access
      Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
      T F Burke, J H Woods, J W Lewis and F Medzihradsky
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 715-721;
    2. You have access
      Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
      L R Gerak, E R Butelman, J H Woods and C P France
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 993-999;
  11. Woskowska, Z

    1. You have access
      Nitric oxide (NO) inhibits release of acetylcholine from nerves of isolated circular muscle of the canine ileum: relationship to motility and release of nitric oxide.
      L M Hryhorenko, Z Woskowska and J A Fox-Threlkeld
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 918-926;
  12. Wu, H L

    1. You have access
      Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.
      P Nambi, N Elshourbagy, H L Wu, M Pullen, E H Ohlstein, D P Brooks, M A Lago, J D Elliott, J G Gleason and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 755-761;
  13. Wu, W J

    1. You have access
      Ethanol decreases the number and activity of splenic natural killer cells in a mouse model for binge drinking.
      W J Wu, R M Wolcott and S B Pruett
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 722-729;

Y

  1. Yamaguchi, I

    1. You have access
      The differential roles of sympathetic nerve activity in the pathogenesis of antral and corpus lesions induced by indomethacin in rats.
      K Kuratani, H Kodama and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 695-702;
  2. yamazaki, A

    1. You have access
      Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: regional differences and its sites of action.
      Y Itoh, T Ogasawara, T Mushiroi, A yamazaki, Y Ukai and K Kimura
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 884-890;
  3. Yang, X

    1. You have access
      Effect of chronic central treatment with the acetylcholine analog methylcarbamylcholine on cortical nicotinic receptors: correlation between receptor changes and behavioral function.
      X Yang and J J Buccafusco
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 651-659;
  4. Young, A M

    1. You have access
      In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
      E A Walker, M M Makhay, J D House and A M Young
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 959-968;
  5. Yu, B

    1. You have access
      Interleukin-1 beta inhibits synaptic transmission and induces membrane hyperpolarization in amygdala neurons.
      B Yu and P Shinnick-Gallagher
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 590-600;

Z

  1. Zaczek, R

    1. You have access
      Studies on the role of K+, Cl- and Na+ ion permeabilities in the acetylcholine release enhancing effects of linopirdine (DuP 996) in rat cortical slices.
      C M Maciag, A R Logue, W J Tinker, J A Saydoff, S W Tam and R Zaczek
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 891-897;
  2. Zalcman, S

    1. You have access
      Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system.
      S Zalcman, J M Green-Johnson, L Murray, W Wan, D M Nance and A H Greenberg
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 977-982;
  3. Zhou, L

    1. You have access
      Role of vascular alpha-1 adrenoceptor subtypes in the pressor response to sympathetic nerve stimulation in the pithed rat.
      H M Vargas, L Zhou and A J Gorman
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 748-754;
  4. Zimmerman, T E

    1. You have access
      Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis.
      M B Grisham, R D Specian and T E Zimmerman
      Journal of Pharmacology and Experimental Therapeutics November 1994, 271 (2) 1114-1121;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 271, Issue 2
1 Nov 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics